Skip to main content

Context is king: Why metadata determines the value of research data (Part 1)

In the age of AI, metadata can be your most valuable, untapped asset, helping to unlock the full value of research investments. This two-part metadata series explains value of metadata management, common challenges, and solutions for the future in life sciences research and development (R&D) data.

Key takeaways:

  • The value of metadata management: Capturing the necessary metadata gives research data the proper context to be useful as substrate for AI.
  • The challenges of managing metadata: Research data challenges include capture, standardization, and integration.
  • The high-level solutions: Using automation at every phase of research workflows for more efficient R&D.
  • The valuable outcome: More time for scientists to focus on discovery while improving data quality, findability, and reusability.

Metadata: The foundation of next-generation R&D in the age of AI

Biopharmaceutical R&D organizations are making significant bets on artificial intelligence (AI). Recent breakthroughs have demonstrated the technology’s transformative potential in accelerating drug discovery.1 With R&D executives remaining bullish about AI’s impact(4)2 and industry investment projected to reach between $5.65 billion to $25 billion by 2030,3 companies are racing to harness this technology to enhance insight generation and improve automation of laboratory work and data flows.

However, much of the recent innovation has been driven by models widely available across the industry. To truly drive a competitive advantage with AI, companies will need to utilize proprietary research data to train their own models, or fine-tune existing models. However, research data notoriously lacks the proper metadata context—ranging from experimental design, assay conditions, and other critical background—to effectively train these models for use in drug discovery. Companies that fail to address these foundational data and metadata challenges could potentially struggle to capitalize on AI’s promise. Strategic industry efforts recognize that high-quality, contextualized, cross-collaboration research data is essential to fuel the next generation of AI-driven discovery.

Here’s an overview as to why contextualized, cross-collaboration research tools will give research companies the greatest competitive advantage.


Why metadata is the real competitive differentiator in AI-driven R&D

Proper metadata capture helps retain this important context and extend the value of research data for both data interoperability and AI usage. Additionally, the rich annotation of research data enables companies to achieve the “laboratory in the loop” effect, which ultimately connects lab experimental results back to the models that predicted the outcome of those experiments so that the technology can learn and get better over time.

In today’s laboratory environment, the failure to capture broad metadata, even beyond what is necessary to complete the experiment at hand, is prevalent. Scientists are often not incentivized to invest the time to capture the necessary context that makes that data useful beyond its initial purpose. And for good reason, it is often very laborious to do so . Solving this friction of metadata capture for scientists will be an important step in making research data “AI-ready.”

In a similar manner, Deloitte and Amazon Web Services (AWS) are fueling the next generation of AI-driven discovery with our Lab of the Future solution suite of cloud-based accelerators that properly and automatically capture, structure, and link metadata to experimental results, all to help scientific organizations realize meaningful returns.


Metadata is also essential for the next generation of pharmaceutical R&D workflows

It is becoming clear that agentic systems can autonomously solve more complex automation problems when provided with properly contextualized data. Therefore, scientific workflows combined with autonomous lab systems become a force multiplier for productivity enhancements at an organizational scale. Without the proper metadata, however, these systems and laboratory automations do not have sufficient context to elevate decision-making and problem-solving from simple, rule-based processing to a cognitive, agentic workflow capable of dealing with unexpected circumstances.

Metadata encompasses all information surrounding experimental design, conditions, and results, giving researchers the contextual framework needed to accurately interpret observations. The scope of metadata is vast and dynamic, with its structure and necessary elements changing across experiments and over time.

Research programs often build upon prior work and knowledge that informs future experimental design. Researchers rely on the associated metadata that encompasses study intent, protocol nuances, and the human decisions during data collection and analysis. Because of this complexity, formalizing the capture of metadata is crucial for maximizing and preserving the value of research data, even as what counts as “necessary” metadata evolves alongside scientific progress.


Key challenges in metadata management

As organizations strive to create FAIR (Findable, Accessible, Interoperable, and Reusable) research data , a key challenge lies in managing metadata effectively across three interconnected dimensions.

Capture
Metadata capture frequently relies on manual entry across siloed tools, fragmented workflows, and inconsistent ontologies, making it difficult for scientists to document contextual metadata. As a result, critical details are often captured as free text, recorded inconsistently, entered manually (often with errors), or omitted altogether. When essential context is not embedded naturally within the scientific workflow, experimental data quickly loses interpretability and reusability.

Standardization
Without shared standards, metadata becomes fragmented as teams and systems use their own conventions and terminology. Cross-study analysis becomes nearly impossible because data fields from different labs or systems can’t be directly compared, and manual mapping is slow and error-prone. This lack of alignment keeps valuable data siloed and unable to be referenced or integrated into future research.

Integration
Research metadata resides across a fragmented landscape of legacy and modern systems, each responsible for distinct domains including projects, experiments, samples, and instruments. The absence of seamless integration across these hierarchical metadata domains creates barriers to reconstructing the full experiment context and lineage. This limits organizational visibility across programs and modalities, undermines end-to-end traceability, and impedes the realization of enterprise-scale analytics, AI, and innovation.

These challenges matter because without systemic change, persistent metadata gaps perpetuate inefficiency, limit reusability, and erode the long-term value of scientific research.


Vision for the future of metadata curation and management

The laboratory of the future will require solutions that automate the collection of metadata throughout all phrases of research and improve the quality of experimental records. The most useful automated workflows will do three things:

  1. Automate metadata capture while driving experimental design and planning
    In the future, metadata management will likely shift from a post hoc retrieval to an active capture process beginning with the planning and design of experiments. Intelligent digital agents could record scientists’ intent in real time using voice or text input, extract essential experimental parameters during planning, and surface-related protocols from prior studies. These systems may prompt scientists to provide missing metadata, automate routine tasks like sample selection and scheduling, and ensure best practices for experimental design are followed—capturing not just experimental details, but also scientific rationale and project-level context.

  2. Create real-time metadata capture during experiment execution
    Following the paradigm shift from passive to proactive systems, metadata collection during the experimental process will likely involve agents prompting continuous voice or photographic updates as experiments run. Every action, on-the-fly adjustment, and outcome may be logged automatically, with routine lab work handled by automated processes that are integrated with downstream systems, such as Laboratory Information Management Systems (LIMS) or Electronic Lab Notebooks (ELNs). This integration could capture both acquisition parameters like s ng rates and environmental variables such as ambient temperature to actively capture experimental, instrument, sample, and reagent metadata.

  3. Build fully contextualized, ready-to-use data products
    As a result of automated metadata capture, experimental data and analyses will likely flow directly into centralized cloud-based locations. Scalable pipelines could parse data files and annotate them in real time with relevant metadata to form ready-to-use data products. Pipelines may also use relevant ontologies to standardize metadata fields and values for seamless integration and interoperability, while intelligent agents could catalog each new entry and suggest additional or missing metadata fields to enrich the context. These systems may also capture details of the data processing pipeline, ensuring every data product is fully contextualized and easy to leverage for future analysis.

 

Figure 1: Metadata collection and standardization can be automated throughout the experimental process. This in turn will empower data-driven research processes and preserve the value of organizational R&D data.

Metadata management helps unlock improvement and efficiencies in R&D

This vision represents a fundamental change in ways of working in R&D. The technology that will enable this transformation will allow researchers to generate and consume scientific data through natural language queries, intelligent agents, and self-documenting systems. By automating metadata capture and management across every phase of research, these solutions free up scientists capacity to focus on discovery while improving data quality, findability, and reusability. This approach will empower data-driven and efficient research practices that will generate more transparent and informed decision-making.

Sign up to receive part 2 of this metadata series before it’s published. We’ll explore the Deloitte and AWS technology that’s solving the challenges of metadata management and turning the vision of the lab of the future into a reality.

 

Endnotes
1. OpenAI, “GPT-5 lowers the cost of cell-free protein synthesis,” February 5, 2026; Insilico Medicine, “Insilico Medicine announces 2025 annual results, redefining value delivery in AI-powered drug discovery,” press release, March 29, 2026; Apheris, “AI Structural Biology (AISB) Network,” accessed May 2026.

2. Pete Lyons et al., 2026 Life Sciences Outlook, Deloitte Insights, December 9, 2025.

3. Knowledge Sourcing Intelligence (KSI), “Artificial intelligence (AI) in life sciences market expected to reach USD 5.650 billion by 2030,” press release, December 26, 2025; Coherent Market Insights, Artificial intelligence in life science market size and share analysis – Growth trends and forecasts (2026–2033), March 30, 2026; Chris Bourne, “Pharma at an inflection point: Where capital, technology and geography are reshaping drug development between 2024 and 2025,” FounderNest, November 22, 2025.

Did you find this useful?

Thanks for your feedback